A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro
Open Access
- 29 November 2021
- journal article
- research article
- Published by Elsevier in Cell Reports Methods
- Vol. 1 (8) , 100122
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Japan Agency for Medical Research and Development (JP20fk0410015)
- Japan Agency for Medical Research and Development (JP21fk0410023)
- Japan Agency for Medical Research and Development (JP19fk0410009)
- Japan Agency for Medical Research and Development (JP19fk0410014)
- Japan Society for the Promotion of Science (JP17890606)
- National Center for Global Health and Medicine (20A1018)
- National Center for Global Health and Medicine (20K17480)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 68 references indexed in Scilit:
- Altering cell death pathways as an approach to cure HIV infectionCell Death & Disease, 2013
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus ReactivationImmunity, 2012
- Integrative genomics viewerNature Biotechnology, 2011
- Establishment of HIV Latency in Primary CD4+Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb RestrictionJournal of Virology, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional ReadthroughCell Host & Microbe, 2008
- Activity against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4′-Ethynyl-2-Fluoro-2′-DeoxyadenosineAntimicrobial Agents and Chemotherapy, 2007
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004
- Modelling viral and immune system dynamicsNature Reviews Immunology, 2002
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997